Molekule for Allergic Rhinitis/Asthma
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03627689|
Recruitment Status : Terminated (Poor accural)
First Posted : August 13, 2018
Last Update Posted : February 5, 2019
|Condition or disease||Intervention/treatment||Phase|
|Asthma Allergic Rhinitis Allergic Conjunctivitis||Other: Active air purifier in respiratory allergies/asthma Other: Sham air purifier||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||49 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Molekule for Allergic Rhinitis/Asthma|
|Actual Study Start Date :||July 13, 2018|
|Actual Primary Completion Date :||January 31, 2019|
|Actual Study Completion Date :||January 31, 2019|
Experimental: Active air purifier arm
Active portable air purifier for 1 month at bedside
Other: Active air purifier in respiratory allergies/asthma
Continuous use of air purifier to improve allergies and asthma control
Sham Comparator: Sham air purifier arm
Placebo portable air purifier for 1 month at bedside
Other: Sham air purifier
- Control of Allergic Rhinitis and Asthma Test (CARAT) score [ Time Frame: 4 weeks ]
CARAT will measure the change in control scores of respiratory allergies and asthma.
Scale 0 (Worse control of allergy and asthma) to 30 (Best control of allergy and asthma). The higher score the better control of allergy and asthma.
There are 10 individual questions, scoring from 0-3.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03627689
|United States, California|
|San Francisco, California, United States, 94103|
|Principal Investigator:||Nikhil G Rao, MD||Molekule|